NHEJ is useful to knock-out gain-of-function or dominant-negative mutations such as Rhodopsin (Rho) gene mutations in autosomal dominant retinitis pigmentosa (ADRP) [78,79]. Here, RHO is linked to autosomal dominant retinitis pigmentosa.